PHARM.ASPHARM.ASAMS
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank46
3Y CAGR-17.1%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-17.1%/yr
vs +275.9%/yr prior
Acceleration
-293.0pp
Decelerating
Percentile
P46
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 7.08% |
| Q2 2025 | 19.04% |
| Q1 2025 | -12.04% |
| Q4 2024 | 17.93% |
| Q3 2024 | 3.31% |
| Q2 2024 | 40.24% |
| Q1 2024 | -29.81% |
| Q4 2023 | 14.95% |
| Q3 2023 | 18.70% |
| Q2 2023 | 27.83% |
| Q1 2023 | -20.44% |
| Q4 2022 | -6.77% |
| Q3 2022 | 12.44% |
| Q2 2022 | 10.49% |
| Q1 2022 | 2.16% |
| Q4 2021 | 0.00% |
| Q2 2021 | 20.04% |
| Q1 2021 | -39.57% |
| Q4 2020 | 18.69% |
| Q3 2020 | 30.48% |
| Q2 2020 | -17.13% |
| Q1 2020 | 0.35% |
| Q4 2019 | 17.69% |
| Q3 2019 | -3.94% |
| Q2 2019 | 27.53% |
| Q1 2019 | 0.17% |
| Q4 2018 | -12.07% |
| Q3 2018 | 37.54% |
| Q2 2018 | -8.38% |
| Q1 2018 | -14.51% |
| Q4 2017 | 33.44% |
| Q3 2017 | 63.54% |
| Q2 2017 | 9.91% |
| Q1 2017 | 160.58% |
| Q4 2016 | 126.95% |
| Q3 2016 | 32.80% |
| Q2 2016 | 6.13% |
| Q1 2016 | 41.91% |
| Q4 2015 | -41.13% |
| Q3 2015 | -11.70% |